Up a level |
2021
Schmidt, L., Jensen, B-E O., Walker, A., Keitel-Anselmino, V, di Cristanziano, V, Boehm, M., Knops, E., Heger, E., Kaiser, R., de Luca, A., Oette, M., Haeussinger, D., Timm, J., Fuchs, A. and Luebke, N. (2021). Torque Teno Virus plasma level as novel biomarker of retained immunocompetence in HIV-infected patients. Infection, 49 (3). S. 501 - 510. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-0973
2020
Neuhann, F., de Forest, A., Heger, E., Nhlema, A., Scheller, C., Kaiser, R., Steffen, H. M., Tweya, H., Faetkenheuer, G. and Phiri, S. (2020). Pretreatment resistance mutations and treatment outcomes in adults living with HIV-1: a cohort study in urban Malawi. Aids Res. Ther., 17 (1). LONDON: BMC. ISSN 1742-6405
2018
Braun, P., Wiesmann, F., Naeth, G., Daeumer, M., Ehret, R., Kaiser, R., Noah, C., Obermeier, M., Schalasta, G., Tiemann, C., Wolf, E. and Knechten, H. (2018). Multicentre evaluation of two next-generation HIV-1 quantitation assays, Aptima Quant Dx and Cobas 6800, in comparison to the RealTime HIV-1 reference assay. J. Int. AIDS Soc., 21. CHICHESTER: JOHN WILEY & SONS LTD. ISSN 1758-2652
Cuypers, L., Vrancken, B., Fabeni, L., Di Maio, V. C., Cento, V., Baele, G., Parczewski, M., Chulanov, V., Gomes, P., Beloukas, A., Geretti, A. M., Dietz, J., Sarrazin, C., Neary, M., Degascun, C., Sierra, S., Kaiser, R., Jimenez, A. B. P., Garcia, F. G., Zazzi, M., Vandamme, A. -M. and Silberstein, F. C. (2018). Inferring the migration routes of hepatitis C virus subtype 1a lineages identifies a need for pan-European prevention strategies. J. Hepatol., 68. S. S158 - 2. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1600-0641
Heger, E., Peters, S., Onyuro, M., Kuemmerle, T., Voigt, E., Di Cristanziano, V., Sierra, S., Huesgen, L., Kulartz, H., Kaiser, R., Wyen, C. and Knops, E. (2018). Longitudinal analysis of proviral HIV-DNA. J. Int. AIDS Soc., 21. CHICHESTER: JOHN WILEY & SONS LTD. ISSN 1758-2652
Knops, E., Heger, E., Koenig, C., Moebius, U., Luebke, N., Kaiser, R., Di Cristanziano, V., Huesgen, L., Kocyigit, C., Rupp, J. and Sierra, S. (2018). Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection. Clin. Microbiol. Infect., 24 (4). S. 440 - 442. OXFORD: ELSEVIER SCI LTD. ISSN 1469-0691
Luebke, N., Jensen, B., Huettig, F., Obermeier, M., Thielen, A., Kaiser, R., Timm, J. and Haeussinger, D. (2018). Failure of dolutegravir first-line cART with selection of R263K and G118R. J. Int. AIDS Soc., 21. CHICHESTER: JOHN WILEY & SONS LTD. ISSN 1758-2652
Pett, S. L., Amin, J., Horban, A., Andrade-Villanueva, J., Losso, M., Porteiro, N., Madero, J. S., Belloso, W., Tu, E., Silk, D., Kelleher, A., Harrigan, R., Clark, A., Sugiura, W., Wolff, M., Gill, J., Gatell, J., Clarke, A., Ruxrungtham, K., Prazuck, T., Kaiser, R., Woolley, I., Alberto Arnaiz, J., Cooper, D., Rockstroh, J. K., Mallon, P. and Emery, S. (2018). Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study. HIV Med., 19 (1). S. 65 - 72. HOBOKEN: WILEY. ISSN 1468-1293
Schloesser, M., Kartashev, V., Mikkola, V., Shemsura, A., Kolpakov, D., Suladze, A., Tverdokhlebova, T., Saukhat, S., Kaiser, R., Heger, E., Knops, E., Boehm, M., Hutt, K. and Sierra, S. (2018). Molecular epidemiology of HIV-1 in South Russia and neighbouring regions. J. Int. AIDS Soc., 21. CHICHESTER: JOHN WILEY & SONS LTD. ISSN 1758-2652
Verheyen, J., Thielen, A., Luebke, N., Dirks, M., Widera, M., Dittmer, U., Kordales, L., Daeumer, M., de Jong, D., Wensing, A., Kaiser, R., Nijhuis, M. and Esser, S. (2018). Rapid rebound of a highly replication competent preexisting CXCR4-tropic HIV variant after allogeneic stem cell transplantation with CCR5D32 stem cells. J. Int. AIDS Soc., 21. S. 4 - 5. CHICHESTER: JOHN WILEY & SONS LTD. ISSN 1758-2652
di Cristanziano, V., Burkert, K., Dieplinger, G., Kann, M., Grundmann, F., Kurschat, C., Benzing, T., Stippel, D., Klein, F., Kaiser, R. and Mueller, R. U. (2018). PRESENTATION OF A PROSPECTIVE STUDY DESIGN FOR THE EVALUATION OF THE ANTIVIRAL IMMUNE RESPONSE AS AN INDICATOR OF THE INTENSITY OF IMMUNOSUPPRESSION AND OUTCOME AFTER KIDNEY TRANSPLANTATION. Transpl. Int., 31. S. 35 - 37. HOBOKEN: WILEY. ISSN 1432-2277
2016
Colagrossi, L., Hermans, L. E., Salpini, R., Pas, S. D., Alvarez, M., Ben Ari, Z., Boland, G., Bruzzone, B., Coppola, N., Seguin-Devaux, C., Dyda, T., Garcia, F., Kaiser, R., Kose, S., Krarup, H., Lazarevic, I., Lunar, M. M., Maylin, S., Micheli, V., Mor, O., Paraschiv, S., Paraskevis, D., Poljak, M., Puchhammer-Stoeckl, E., Simon, F., Stanojevic, M., Stene-Johansen, K., Tihic, N., Trimoulet, P., Verheyen, J., Vince, A., Weis, N., Yalcinkaya, T., Lepej, S. Z., Boucher, C. A., Wensing, A. M., Perno, C. F. and Svicher, V. (2016). IMMUNE-ESCAPE MUTATIONS AND STOP-CODONS IN HBSAG CIRCULATES IN A RELEVANT PROPORTION OF PATIENTS WITH CHRONIC HBV INFECTION EXPOSED TO ANTI-HBV DRUGS IN EUROPE: IMPLICATIONS FOR HBV TRANSMISSION IN THE SETTING OF VACCINATION AND DISEASE PROGRESSION. J. Hepatol., 64. S. S367 - 2. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1600-0641
Knops, E., Kalaghatgi, P., Neumann-Fraune, M., Heger, E., Schuelter, E., Lengauer, T., Keitel, V., Goeser, T., Schuebel, N., von Hahn, T., Peuser, I., Qurishi, N., Roemer, K., Scholten, S., Daeumer, M., zur Wiesch, J. S., Baumgarten, A., Obermeier, M., Walter, H., Kaiser, R. and Sierra, S. (2016). HEPATITIS C VIRUS SCREENING PROJECT OF PATIENTS ON CURRENT ANTI-HCV THERAPY. J. Hepatol., 64. S. S402 - 1. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1600-0641
Knops, E., Kobbe, G., Kaiser, R., Luebke, N., Dunay, G., Fischer, J., Huettig, F., Wensing, A., Haas, R., Nijhuis, M., Martinez-Picado, J., Haeussinger, D. and Jensen, B. (2016). Treatment of HIV and acute myeloid leukemia by allogeneic CCR5-d32 blood stem cell transplantation. J. Clin. Virol., 82. S. S86 - 1. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1873-5967
Kobbe, G., Knops, E., Luebke, N., Kaiser, R., Nachtkamp, K., Dunay, G. A., Kobbe, R., Fischer, J. C., Huettig, F., Haas, R., Haeussinger, D. and Jensen, B. E. O. (2016). Elimination of HIV in a patient with AML after allogeneic blood stem cell transplantation from a CCR5-d32 donor. Bone Marrow Transplant., 51. S. S268 - 2. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
Noguera-Julian, M., Cozzi-Lepri, A., Di Giallonardo, F., Schuurman, R., Daumer, M., Aitken, S., Ceccherini-Silberstein, F., Monforte, A. D'Arminio, Geretti, A. M., Booth, C. L., Kaiser, R., Michalik, C., Jansen, K., Masquelier, B., Bellecave, P., Kouyos, R. D., Castro, E., Furrer, H., Schultze, A., Guenthard, H. F., Brun-Vezinet, F., Metzner, K. J. and Paredes, R. (2016). Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type I variants. Clin. Microbiol. Infect., 22 (2). S. 191 - 201. OXFORD: ELSEVIER SCI LTD. ISSN 1469-0691
Posdzich, P., Herling, M., Chemnitz, J., Leitzke, S., Di Christanziano, V, Hoeller, K., Kaiser, R., Scheid, C. and Holtick, U. (2016). BKV disease during the first 100 days after allogeneic hematopoietic stem cell transplantation - results of a screening program and retrospective analysis. Oncol. Res. Treat., 39. S. 80 - 81. BASEL: KARGER. ISSN 2296-5262
2015
Eberhardt, K. A., Sarfo, F. S., Kuffour, E. O., Dompreh, A., Klupp, E. M., Aepfelbacher, M., Geldmacher, C., Kaiser, R., di Cristanziano, V., Burchard, G. and Feldt, T. (2015). Prevalence and clinical implications of Tropheryma whipplei in stools of HIV-positive and HIV-negative individuals in Ghana. Trop. Med. Int. Health, 20. S. 261 - 262. HOBOKEN: WILEY-BLACKWELL. ISSN 1365-3156
Kaiser, R., Knops, E., Neumann-Fraune, M., Timmen-Wego, M., Gaertner, B. and Adams, O. (2015). The Respiratory Virus Network - An initiative to collect and provide data on respiratory virus diseases via internet. J. Clin. Virol., 70. S. S44 - 1. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1873-5967
Rupp, D., Dietz, J., Sikorski, M. A., Sierra, S., Brown, R., Pietschmann, T., Kaiser, R., Sarrazin, C. and Bartenschlager, R. (2015). A phenotypic NS3-protease inhibitor resistance assay to characterize resistance-associated mutations in patients. J. Viral Hepatitis, 22. S. 93 - 94. HOBOKEN: WILEY-BLACKWELL. ISSN 1365-2893
Teutsch, K., Schweitzer, F., Knops, E., Kaiser, R., Pfister, H., Verheyen, J., Goebel, H., Cingoez, T. and Di Cristanziano, V. (2015). Early identification of renal transplant recipients with high risk of polyomavirus-associated nephropathy. Med. Microbiol. Immunol., 204 (6). S. 657 - 665. NEW YORK: SPRINGER. ISSN 1432-1831
Wiesmann, F., Naeth, G., Sarrazin, C., Berger, A., Kaiser, R., Ehret, R., Knechten, H. and Braun, P. (2015). Variation analysis of six HCV viral load assays using low viremic HCV samples in the range of the clinical decision points for HCV protease inhibitors. Med. Microbiol. Immunol., 204 (4). S. 515 - 526. NEW YORK: SPRINGER. ISSN 1432-1831
2014
Bastys, T., Doncheva, N. T., Walter, H., Kaiser, R., Albrecht, M. and Kalinina, O. V. (2014). Molecular mechanisms of HIV-1 protease resistance and resensitization towards lopinavir and saquinavir upon L76V mutation. Antivir. Ther., 19. S. A154 - 1. LONDON: INT MEDICAL PRESS LTD. ISSN 1359-6535
Beggel, B., Sikorski, A. -M., Sierra-Aragon, S., Lengauer, T. and Kaiser, R. (2014). UPDATED geno2pheno[HCV] WEB SERVICE PERFORMS RESISTANCE ANALYSIS BASED ON NS3, NS5A AND NS5B SEQUENCE DATA. J. Hepatol., 60 (1). S. S446 - 1. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1600-0641
Dirks, M., Pfeifer, N., Schuelter, E., Esser, S., Faetkenheuer, G., Jenssen, B., Kaiser, R. and Verheyen, J. (2014). Insertions and deletions in p6-gag correlate with the predicted cellular tropism of HIV-1 V3 sequences. Antivir. Ther., 19. S. A116 - 1. LONDON: INT MEDICAL PRESS LTD. ISSN 1359-6535
Kordelas, L., Verheyen, J., Beelen, D. W., Horn, P. A., Heinold, A., Kaiser, R., Trenschel, R., Schadendorf, D., Dittmer, U. and Esser, S. (2014). Shift of HIV-Tropism in a HIV-patient with large cell anaplastic T-cell-lymphoma undergoing allogeneic stem cell transplantation from a donor with homozygosity for the CCR5 delta32 mutation. Oncol. Res. Treat., 37. S. 38 - 39. BASEL: KARGER. ISSN 2296-5262
Pironti, A., Pfeifer, N., Kaiser, R., Walter, H. and Lengauer, T. (2014). Accurate prediction of drug-exposure without using established drug-resistance mutations. Antivir. Ther., 19. S. A75 - 1. LONDON: INT MEDICAL PRESS LTD. ISSN 1359-6535
Pironti, A., Sierra, S., Kaiser, R., Lengauer, T. and Pfeifer, N. (2014). Simulation of Sanger-sequencing errors in the context of genotypic tropism determination. Antivir. Ther., 19. S. A81 - 1. LONDON: INT MEDICAL PRESS LTD. ISSN 1359-6535
Schuelter, E., Kaiser, R., Zazzi, M., Soennerborg, A., Camacho, R. and Verheyen, J. (2014). Time on drug analysis based on real life data. Antivir. Ther., 19. S. A133 - 1. LONDON: INT MEDICAL PRESS LTD. ISSN 1359-6535
Schweitzer, F., Pfeifer, N., Kaiser, R., Jensen, B., Faetkenheuer, G., Esser, S. and Trapp, S. (2014). Model to investigate host-specific innate and adaptive immune responses in therapy-naive HIV-1 infected patients. Antivir. Ther., 19. S. A158 - 1. LONDON: INT MEDICAL PRESS LTD. ISSN 1359-6535
Sierra, S., Sikorski, A. M., Beggel, B., Lengauer, T., Goeser, T., Esser, S., Qurishi, N., Haeussinger, D. and Kaiser, R. (2014). Molecular epidemiology of HCV infection in the State of North Rhine-Westphalia (Germany). Antivir. Ther., 19. S. A72 - 1. LONDON: INT MEDICAL PRESS LTD. ISSN 1359-6535
Sikorski, A. M., Sierra, S., Rupp, D., Beggel, B., Lengauer, T., Goeser, T., Qurishi, N., Scholten, S., Bartenschlager, R. and Kaiser, R. (2014). Phenotypic analysis of patients on current anti-HCV therapy. Antivir. Ther., 19. S. A110 - 1. LONDON: INT MEDICAL PRESS LTD. ISSN 1359-6535
2012
Obermeier, M., Camacho, R., Charpentier, C., Descamps, D., Eberle, J., Guertler, L., Ruelle, J., Pironti, A., Brun-Vezinet, F., Stuermer, M. and Kaiser, R. (2012). HIV2EU: supporting standardized HIV-2 drug resistance interpretation in Europe. J. Int. AIDS Soc., 15. S. 135 - 136. CHICHESTER: JOHN WILEY & SONS LTD. ISSN 1758-2652
Obermeier, M., Ehret, R., Berg, T., Braun, P., Korn, K., Mueller, H., Noah, C., Stuermer, M., Thielen, A., Walter, H., Wolf, E. and Kaiser, R. (2012). Genotypic HIV-coreceptor tropism prediction with geno2pheno [coreceptor]: differences depending on HIV-1-subtype. J. Int. AIDS Soc., 15. S. 111 - 112. CHICHESTER: JOHN WILEY & SONS LTD. ISSN 1758-2652
Obermeier, M., Ehret, R., Kaiser, R. and Berga, T. (2012). HIV-1 drug resistance testing at low viral load may help to differentiate between ongoing replication and release from reservoirs. J. Int. AIDS Soc., 15. S. 135 - 136. CHICHESTER: JOHN WILEY & SONS LTD. ISSN 1758-2652
Schuelter, E., Luebke, N., Jensen, B., Zazzi, M., Sonnerborg, A., Lengauer, T., Incardona, F., Camacho, R., Schmit, J., Clotet, B., Kaiser, R. and Pironti, A. (2012). Etravirine in protease inhibitor-free antiretroviral combination therapies. J. Int. AIDS Soc., 15. S. 155 - 157. CHICHESTER: JOHN WILEY & SONS LTD. ISSN 1758-2652
Sierra, S., Dybowski, J., Pironti, A., Gueney, L., Thielen, A., Reuter, S., Esser, S., Faetkenheuer, G., Lengauer, T., Heider, D., Hoffmann, D., Pfister, H., Jensen, B. and Kaiser, R. (2012). Optimisation of baseline genotypic testing for safe and efficient maraviroc administration. J. Int. AIDS Soc., 15. S. 101 - 103. CHICHESTER: JOHN WILEY & SONS LTD. ISSN 1758-2652